We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$63.3B
AUM Growth
+$192M
Cap. Flow
+$1.33B
Cap. Flow %
2.1%
Top 10 Hldgs %
14.31%
Holding
4,981
New
573
Increased
1,406
Reduced
1,427
Closed
1,256

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$561M
2
ACN icon
Accenture
ACN
+$435M
3
MRK icon
Merck
MRK
+$378M
4
NOC icon
Northrop Grumman
NOC
+$339M
5
V icon
Visa
V
+$308M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$439M
2
ZTS icon
Zoetis
ZTS
+$345M
3
MCD icon
McDonald's
MCD
+$343M
4
UNH icon
UnitedHealth
UNH
+$334M
5
SPGI icon
S&P Global
SPGI
+$279M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Industrials 11.25%
3 Healthcare 10.23%
4 Financials 10.22%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAME icon
3551
GameSquare
GAME
$37.7M
$30 ﹤0.01%
25
TRVG
3552
trivago
TRVG
$397M
$30 ﹤0.01%
15
TZOO icon
3553
Travelzoo
TZOO
$76.6M
$30 ﹤0.01%
4
-16,341
-100% -$139K
TCI icon
3554
Transcontinental Realty Investors
TCI
$380M
$28 ﹤0.01%
1
-92
-99% -$2.77K
FNCB
3555
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$28 ﹤0.01%
4
-37,181
-100% -$212K
KUKE
3556
DELISTED
Kuke Music
KUKE
$27 ﹤0.01%
2
ZKIN icon
3557
ZK International Group
ZKIN
$72.2M
$27 ﹤0.01%
7
CYTH
3558
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$27 ﹤0.01%
21
IH
3559
iHuman
IH
$73.6M
$25 ﹤0.01%
14
UBX
3560
DELISTED
Unity Biotechnology
UBX
$25 ﹤0.01%
18
WWR icon
3561
Westwater Resources
WWR
$51.5M
$25 ﹤0.01%
52
CDTX
3562
DELISTED
Cidara Therapeutics
CDTX
$24 ﹤0.01%
2
-1
-33% -$14
ECBK icon
3563
ECB Bancorp
ECBK
$179M
$24 ﹤0.01%
2
-1,034
-100% -$12.8K
FEM icon
3564
First Trust Emerging Markets AlphaDEX Fund
FEM
$735M
$24 ﹤0.01%
1
-344
-100% -$8.27K
ARKG icon
3565
ARK Genomic Revolution ETF
ARKG
$1.54B
$23 ﹤0.01%
1
-2,813
-100% -$71K
CANG
3566
Cango Inc
CANG
$68.9M
$23 ﹤0.01%
1
CBFV icon
3567
CB Financial Services
CBFV
$183M
$23 ﹤0.01%
1
-314
-100% -$6.97K
HYPR icon
3568
Hyperfine
HYPR
$93.1M
$23 ﹤0.01%
27
-119,328
-100% -$105K
ATER icon
3569
Aterian
ATER
$4.19M
$22 ﹤0.01%
8
BMRA icon
3570
Biomerica
BMRA
$4.94M
$22 ﹤0.01%
6
FLNT
3571
Fluent
FLNT
$100M
$22 ﹤0.01%
6
GDC icon
3572
GD Culture Group
GDC
$6.95M
0
VIP
3573
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37.7M
$22 ﹤0.01%
8
LEE icon
3574
Lee Enterprises
LEE
$174M
$22 ﹤0.01%
2
LSF icon
3575
Laird Superfood
LSF
$46.9M
$22 ﹤0.01%
4

Similar funds

Qube Research & Technologies (QRT)'s Q2 2024 Portfolio in Review

As of Q2 2024, Qube Research & Technologies (QRT) held 4,981 positions worth $63.3B, up 0.3% from $63.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Qube Research & Technologies (QRT)'s Q2 2024 filing shows 573 new, 1,406 increased, 1,427 reduced and 1,256 closed positions. Its largest new stake was Coinbase: 273,144 shares worth $60.7M. The largest sale was NVIDIA, an estimated $439M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Qube Research & Technologies (QRT)'s largest Q2 2024 buy was Coinbase: 273,144 shares worth $60.7M.
  • Qube Research & Technologies (QRT) added most to Broadcom in Q2 2024, an estimated $561M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2024 reduction was NVIDIA, cutting an estimated $439M.
  • Qube Research & Technologies (QRT) fully exited Palantir in Q2 2024, selling an estimated $161M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 14% of its $63.3B portfolio in Q2 2024.
  • Qube Research & Technologies (QRT) opened 573 new positions and closed 1,256 in Q2 2024.
  • Qube Research & Technologies (QRT)'s portfolio value rose 0.3% quarter-over-quarter to $63.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.